Dr. Reddy’s Labs Launches Invista In India
Hyderabad, April 13 (Maxim News): Dr. Reddy’s Laboratories Limited launched of Invista, formulation of Dasatinib that is bioequivalent to the innovator brand. It is indicated for the treatment of chronic accelerated or myeloid or lymphoid…